Key Highlights

  • Oura postponed its planned Nasdaq IPO on September 29, 2026, about a day before trading, after seeking up to USD 2.2 billion by selling 50 million shares at USD 40 to USD 44, an implied fully diluted valuation near USD 15.6 billion.
  • The company said demand remained strong, and orders had reportedly reached about four times the shares available, but it cited market uncertainty as rising bond yields pressed new issuance.
  • Only 13.5 million of the 50 million shares were new, with 36.5 million sold by existing holders, so about 73% of the offering was a secondary sale, simple arithmetic on two published numbers.
  • Through mid-September, 109 IPOs had priced in 2026 and raised USD 146.5 billion, down about 30% in count but up nearly 400% in proceeds, according to Renaissance Capital data.

What Happened

The Renaissance IPO ETF (NYSEARCA:IPO) tracks recently listed companies, and the Oura postponement was a blow to that group's pipeline. Oura launched its roadshow on September 21 and was expected to price on Monday and trade on Wednesday. On Tuesday it said it would delay the listing. CEO Tom Hale said the company wants an extraordinary IPO and has the luxury of choosing its moment. No new timetable has been announced. Eli Lilly had signaled interest in up to USD 100 million of shares, and Dragoneer up to USD 300 million. Oura remains private and has no ticker.

Why the Window Narrowed

Rising bond yields drove the retreat. The 10-year Treasury yield hit its highest level since 2007, and a deal-data executive said investors are demanding wider discounts because higher discount rates cut the value of future earnings. Renaissance Capital analysts wrote that third-quarter IPO activity fell below expectations because of concerns about AI spending, bond yields at a 19-year high and the resumption of Fed rate hikes. Holtec Nuclear withdrew its offering earlier this month, and Bamboo Insurance also postponed. The Renaissance IPO ETF (NYSEARCA:IPO) captures sentiment toward newly public companies.

Valuation and Risks

Oura's numbers were strong: nine-month revenue of USD 1.21 billion through June 30, pretax profit of about USD 70 million, 3.6 million rings sold in the year through June and about 5.7 million paid members. Yet the implied valuation of USD 15.62 billion was about 42% above the USD 11 billion set in its late-2025 funding round, simple arithmetic. A University of Florida IPO researcher noted that single-product hardware companies such as GoPro and Peloton performed poorly after their IPOs once growth stalled. Investors should watch whether Oura returns, whether other issuers follow and whether yields ease. The Renaissance IPO ETF (NYSEARCA:IPO) is one gauge.

Where Things Stand

Oura pulled its IPO a day before trading because rising bond yields and market volatility threatened pricing despite strong demand and about four times oversubscription. The Renaissance IPO ETF (NYSEARCA:IPO) reflects an IPO market where large deals still price, but second-tier issuers retreat when yields rise. The balance of evidence is cautious: proceeds in 2026 are high, but the fall calendar is weaker and the pulled deal shows how quickly sentiment can turn. The next catalysts are Oura's new timetable, other pricings and the Fed's October 28 decision.